EICHOR
● Recruiting
Molecular Predictors of Cancer in Patients at High Risk of Lung Cancer
Condition: Lung Cancer · Sponsor: Vanderbilt-Ingram Cancer Center
About this study
RATIONALE: Using samples of blood, urine, sputum, and lung tissue from patients at high risk of cancer for laboratory studies may help doctors learn more about changes that may occur in DNA and identify biomarkers related to cancer. PURPOSE: This research study is looking at molecular predictors of cancer in patients at high risk of lung cancer.
This description comes directly from the study's public registry record.
Talk to the study team
Vanderbilt Ingram Clinical Trials Information Program · 1-800-811-8480
Always discuss trial participation with your own doctor first.
Locations (2)
| Vanderbilt-Ingram Cancer Center | Nashville, Tennessee, United States | Recruiting |
| Veterans Affairs Medical Center - Nashville | Nashville, Tennessee, United States | Recruiting |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT00898313